GW Henssler & Associates’s Cardinal Health CAH Stock Holding History
Bought
Maintained
Sold
Other funds holding CAH
GW Henssler & Associates's CAH Position: Q3 2023 in Review
GW Henssler & Associates sold out of Cardinal Health (CAH) in Q3 2023, closing a stake of 5,621 shares — an estimated $532K sold.
GW Henssler & Associates first reported a position in CAH in Q2 2013 and held it in 22 quarters. The position peaked at $19.9M in Q4 2022. 948 funds tracked by Wall St. Rank hold CAH as of Q3 2023.
- GW Henssler & Associates reported no remaining Cardinal Health position as of Q3 2023 after selling out during the quarter.
- GW Henssler & Associates sold 5,621 Cardinal Health shares in Q3 2023, an estimated $532K.
- GW Henssler & Associates first reported a position in Cardinal Health in Q2 2013 and held it in 22 quarters.
- GW Henssler & Associates's Cardinal Health position peaked at $19.9M in Q4 2022.
- 948 funds tracked by Wall St. Rank held Cardinal Health as of Q3 2023.
Based on GW Henssler & Associates's 13F filing for Q3 2023, filed 24 Oct 2023.